An update of phase 2 trial results: Patients with recurrent malignant glioma treated with iodine 131-labeled murine antitenascin monoclonal antibody 81C6 into the resection cavity
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Reardon, D; Akabani, G; Friedman, A; Friedman, H; McLendon, R; Quinn, J; Rich, J; Vredenburgh, J; Zalutsky, M; Bigner, D
Published Date
- July 1, 2005
Published In
Volume / Issue
- 7 / 3
Start / End Page
- 311 - 311
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 1522-8517
Conference Name
- 2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Conference Location
- Edinburgh, SCOTLAND
Conference Start Date
- May 5, 2005
Conference End Date
- May 8, 2005